BioMarin’s stock falls after another company’s dwarfism drug moves into Phase 3 clinical trials

Brasil Notícia Notícia

BioMarin’s stock falls after another company’s dwarfism drug moves into Phase 3 clinical trials
Brasil Últimas Notícias,Brasil Manchetes
  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 97%

Shares of BioMarin Pharmaceutical Inc. were down about 6.0% in premarket trading on Monday after BridgeBio Pharma Inc. shared positive Phase 2 clinical data...

Shares of BioMarin Pharmaceutical Inc. BMRN were down about 6.0% in premarket trading on Monday after BridgeBio Pharma Inc. BBIO shared positive Phase 2 clinical data about its experimental dwarfism drug, which could compete with BioMarin’s Voxzogo if and when it’s approved. BioMarin received Food and Drug Administration approval for Voxzogo as a treatment for some children 5 years old and older with achondroplasia in late 2021. The drug generated about $169 million in sales last year.

... Shares of BioMarin Pharmaceutical Inc. BMRN were down about 6.0% in premarket trading on Monday after BridgeBio Pharma Inc. BBIO shared positive Phase 2 clinical data about its experimental dwarfism drug, which could compete with BioMarin’s Voxzogo if and when it’s approved. BioMarin received Food and Drug Administration approval for Voxzogo as a treatment for some children 5 years old and older with achondroplasia in late 2021. The drug generated about $169 million in sales last year.

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

MarketWatch /  🏆 3. in US

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

MO Stock Price | Altria Group Inc. Stock Quote (U.S.: NYSE) | MarketWatchMO Stock Price | Altria Group Inc. Stock Quote (U.S.: NYSE) | MarketWatchMO | Complete Altria Group Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Consulte Mais informação »

BridgeBio’s stock rallies 50% on new data from dwarfism therapyBridgeBio’s stock rallies 50% on new data from dwarfism therapyShares of BridgeBio Pharma Inc. soared about 52% in premarket trading on Monday after the company shared positive data from a Phase 2 clinical trial about...
Consulte Mais informação »

MCU Phase 5 Is Already Continuing A Wonderful New Marvel TrendMCU Phase 5 Is Already Continuing A Wonderful New Marvel TrendMarvel Studios' Phase 4 doubled down on a great visual MCU trend, and thankfully, it looks like Phase 5 will be continuing and expanding on it.
Consulte Mais informação »

AUD/USD: Weak phase over? – UOBAUD/USD: Weak phase over? – UOBIn the opinion of UOB Group’s Economist Lee Sue Ann and Markets Strategist Quek Ser Leang, AUD/USD has now likely moved into a consolidative range. Ke
Consulte Mais informação »

Iran completes pre-pilot phase of central bank digital currencyIran completes pre-pilot phase of central bank digital currencyThe Central Bank of Iran plans to increase the scope of the CBDC pilot in the country’s payment system following completion of a pre-pilot phase.
Consulte Mais informação »

German minister says on right track with EU over combustion engine phase-outGerman minister says on right track with EU over combustion engine phase-outGermany's transport minister said on Monday that he was optimistic a row with the European Union over a bid to ban new cars with internal combustion engines could be solved, but added a decision did not need to be made in the coming days.
Consulte Mais informação »



Render Time: 2025-02-27 18:45:32